Zydus Lifesciences Q1 Results

  • BSE: 532321
  • NSE: ZYDUSLIFE
  • ISIN: INE010B01027
  • Sector: Biotechnology & Drugs
BSE
962.714.00 (1.48%)
Volume16.80 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
964.3515.30 (1.61%)
Volume2.66 M
Updated: Mon 25 Nov, 2024 | 15:44:11
Today: 946.35
967.00
52-Wk: 628.05
1,323.90

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Zydus Lifesciences Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
    Total Revenue 6,207.504,667.70-%5,139.60-%
    Selling/ General/ Admin Expenses Total 883.50723.90-%730.40-%
    Depreciation/ Amortization 215.30178.60-%179.80-%
    Other Operating Expenses Total 1,628.701,276.60-%1,202.40-%
    Total Operating Expense 4,313.604,476.40-%3,801.20-%
    Operating Income 1,893.90191.30-%1,338.40-%
    Net Income Before Taxes 1,899.70485.80-%1,329.20-%
    Net Income 1,419.90296.60-%1,086.90-%
    Diluted Normalized EPS 14.117.22-%10.87-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts